Clinical Trial Update: ASIS for Botox in Chronic Migraine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating ASIS using Botox (onabotulinumtoxinA) for chronic migraine occurring more than 15 days per month with attacks lasting 4 hour…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: ASIS Corporation | Conditions: Chronic Migraine More than15 Days Per Month, and Lasting 4 Hours a Day or Longer. | Phase 1, Phase 2 | Status: UNKNOWN